Brain tumors: From childhood through adolescence into adulthood

Journal of Clinical Oncology

Volumn 28, Issue 32, 2010, Pages 4783-4789

  Kieran, Mark W ^a   Walker, David ^a   Frappaz, Didier ^a   Prados, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; PROCARBAZINE; TEMOZOLOMIDE; TIOGUANINE; VINCRISTINE;

ADULT; ASTROCYTOMA; BRAIN DEVELOPMENT; BRAIN TUMOR; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CRANIOPHARYNGIOMA; EPENDYMOMA; GERM CELL TUMOR; GLIOBLASTOMA; GLIOMA; HUMAN; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; OLIGODENDROGLIOMA; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADOLESCENT MEDICINE; ADULT; BRAIN; BRAIN NEOPLASMS; CHILD; CONTINUITY OF PATIENT CARE; GLIOMA; HUMANS; MEDULLOBLASTOMA; NEOPLASMS, GERM CELL AND EMBRYONAL;

EID: 78951494764     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.3481     Document Type: Review

References (42)

1. Bleyer A, Montello M, Budd T, et al: National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation. Cancer 103:1891-1897, 2005
2. Ferrari A, Bleyer A: Participation of adolescents with cancer in clinical trials. Cancer Treat Rev 33:603-608, 2007 (Pubitemid 350047371)
3. Bleyer A: The quid pro quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer 54:238-241, 2010
4. Patton GC, Viner R: Pubertal transitions in health. Lancet 369:1130-1139, 2007 (Pubitemid 46483639)
5. Department of Health: The NHS Cancer Plan. 2001 (http://www.dh.gov.uk/en/ Healthcare/Cancer/DH-107)
6. Ferrari A, Dama E, Pession A, et al: Adolescents with cancer in Italy: Entry into the national cooperative paediatric oncology group AIEOP trials. Eur J Cancer 45:328-334, 2009
7. Casey BJ, Jones RM, Hare TA: The adolescent brain. Ann N Y Acad Sci 1124:111-126, 2008 (Pubitemid 351506787)
8. Gogtay N, Giedd JN, Lusk L, et al: Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101:8174-8179, 2004 (Pubitemid 38698073)
9. Birch JM, Alston RD, Quinn M, et al: Incidence of malignant disease by morphological type, in young persons aged 12-24 years in England, 1979-1997. Eur J Cancer 39:2622-2631, 2003
10. Arora RS, Alston RD, Eden TO, et al: Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol 11:403-413, 2009
11. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007
12. Sano K: Intracranial dysembryogenetic tumors: Pathogenesis and their order of malignancy. Neurosurg Rev 24:162-167, 2001
13. Schneider DT, Calaminus G, Koch S, et al: Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42:169-175, 2004 (Pubitemid 38173928)
14. Oosterhuis JW, Looijenga LH: Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210-222, 2005 (Pubitemid 40314952)
15. Schneider DT, Zahn S, Sievers S, et al: Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol 19:864-873, 2006 (Pubitemid 43780457)
16. Robertson PL, DaRosso RC, Allen JC: Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol 32:71-80, 1997 (Pubitemid 27077884)
17. Matsutani M: Chemoradiotherapy for brain tumors: Current status and perspectives. Int J Clin Oncol 9:471-474, 2004
18. Calaminus G, Bamberg M, Harms D, et al: AFP/beta-HCG secreting CNS germ cell tumors: Long-term outcome with respect to initial symptoms and primary tumor resection - Results of the cooperative trial MAKEI 89. Neuropediatrics 36:71-77, 2005 (Pubitemid 41117124)
19. Dunkel IJ, Finlay JL: High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit Rev Oncol Hematol 41:197-204, 2002 (Pubitemid 34150130)
20. Spreafico F, Massimino M, Gandola L, et al: Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer 41:1304-1310, 2005 (Pubitemid 40813007)
21. Curran EK, Sainani KL, Le GM, et al: Gender affects survival for medulloblastoma only in older children and adults: A study from the Surveillance Epidemiology and End Results Registry. Pediatr Blood Cancer 52:60-64, 2009
22. Lai R: Survival of patients with adult medulloblastoma: A population-based study. Cancer 112:1568-1574, 2008
23. Brandes AA, Franceschi E, Tosoni A, et al: Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110:2035-2041, 2007 (Pubitemid 350036864)
24. Riffaud L, Saikali S, Leray E, et al: Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 111:478-487, 2009
25. Tabori U, Sung L, Hukin J, et al: Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys 64:402-407, 2006 (Pubitemid 43083425)
26. Tabori U, Sung L, Hukin J, et al: Medulloblastoma in the second decade of life: A specific group with respect to toxicity and management - A Canadian Pediatric Brain Tumor Consortium Study. Cancer 103:1874-1880, 2005
27. Bull KS, Spoudeas HA, Yadegarfar G, et al: Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: A follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). J Clin Oncol 25:4239-4245, 2007 (Pubitemid 47548564)
28. Bondy ML, Scheurer ME, Malmer B, et al: Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium. Cancer. 113:1953-1968, 2008 (suppl 7)
29. Louis DN, Ohgaki H, Wiestler OD, et al (eds): WHO classification of tumours of the central nervous system (ed 4). Geneva, Switzerland, WHO Press, 2007
30. Pfister S, Witt O: Pediatric gliomas. Recent Results Cancer Res 171:67-81, 2009
31. Kreiger PA, Okada Y, Simon S, et al: Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 109:387-392, 2005 (Pubitemid 40637311)
32. Raghavan R, Balani J, Perry A, et al: Pediatric oligodendrogliomas: A study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 62:530-537, 2003 (Pubitemid 36560194)
33. Mack SC, Taylor MD: The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 25:1195-1201, 2009
34. Moreno L, Bautista FJ, Zacharoulis S: Outcome of teenagers and young adults with ependymoma: The Royal Marsden experience. Childs Nerv Syst 25:1047-1052, 2009
35. Packer RJ, Ater J, Allen J, et al: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754, 1997 (Pubitemid 27187674)
36. Prados MD, Edwards MS, Rabbitt J, et al: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32:235-241, 1997 (Pubitemid 27077974)
37. Heath JA, Turner CD, Poussaint TY, et al: Chemotherapy for progressive low-grade gliomas in children older than ten years: The Dana-Farber experience. Pediatr Hematol Oncol 20:497-504, 2003 (Pubitemid 37248192)
38. Sievert AJ, Fisher MJ: Pediatric low-grade gliomas. J Child Neurol 24:1397-1408, 2009
39. Schomas DA, Laack NN, Brown PD: Low-grade gliomas in older patients: Long-term follow-up from Mayo Clinic. Cancer 115:3969-3978, 2009
40. MacConaill LE, Campbell CD, Kehoe SM, et al: Profiling critical cancer gene mutations in clinical tumor samples. PLoS One 4:e7887, 2009
41. Pfister S, Janzarik WG, Remke M, et al: BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739-1749, 2008 (Pubitemid 351632377)
42. Jones DT, Kocialkowski S, Liu L, et al: Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 28:2119-2123, 2009